SparingVision Strengthens Management Team

SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer

SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal Dystrophies

SparingVision wins First Prize at EIT European Health Catapult competition

SparingVision to Present at the Ophthalmology Innovation Summit (OIS) in Chicago on July 25th, 2019 during the American Society of Retinal Specialists (ASRS) meeting

SparingVision awarded at EIC Accelerator program (H2020 SME instrument Phase 2), securing funding of €2.5 million

SparingVision sélectionnée au programme européen EIC Accelerator (H2020 SME instrument Phase 2) pour un financement de 2,5 millions d’euros

SparingVision to present preclinical datas for Retinitis Pigmentosa’s treatment during Annual Congress of the Association for Research in Vision and Ophthalmology (ARVO)

Journée Internationale des Maladies Rares

SparingVision récompensée par le « Mercure des Entrepreneurs HEC 2019 » dans la catégorie « Création d’Entreprise »

SparingVision sélectionnée pour une présentation publique au 10e Biotech Showcase™

SparingVision to Participate in the 10th Annual Biotech Showcase in San Francisco,

1 For Release: July 12, 2017 Contact: Rhea Farberman, Foundation Fighting Blindness 410-423-0635 SparingVision Wins Grand Prize of 2017 i-Lab Contest for New, Innovative French Companies